Belluscura PLC (AIM:BELL), which makes portable oxygen concentrators for people who struggle to breathe, has withdrawn its financial guidance for the current year due to the new US tariffs on China.
The medical device maker said a "significant proportion" of its oxygen concentrators, raw materials and component parts are currently manufactured in China, where President Trump has imposed a 34% tariff, rising to 54% on some goods.
The Anglo-US company added in the statement on Tuesday morning that it is "assessing the potential financial implications, risks and opportunities" of the tariffs.
It expects to make another statement once it has done this, including keeping an eye on possible subsequent developments.
Further developments have come thick and fast this week, with Trump threatening to impose an additional tariff of 50% on China on Monday and then China today vowing to "fight to the end" against the US tariffs.